Advanced Cancer

Showing NaN - NaN of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

Active, not recruiting
  • Cancer
  • +3 more
  • Austin, Texas
  • +3 more
Jan 18, 2023

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in Sarasota, Nashville (DS-9606a)

Recruiting
  • Advanced Cancer
  • +3 more
  • Denver, Colorado
  • +6 more
Jan 12, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Advanced Cancer Trial in Worldwide (Avelumab, Utomilumab, PF-04518600)

Active, not recruiting
  • Advanced Cancer
  • Encinitas, California
  • +87 more
Dec 7, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Advanced Cancer, Pleural Effusion Trial in Houston (Intrapleural catheter (IPC) drained, IPC Placement, Chest X-Ray)

Active, not recruiting
  • Advanced Cancer
  • Pleural Effusion
  • Intrapleural catheter (IPC) drained
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain, United States (FS120)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • New Haven, Connecticut
  • +7 more
Aug 8, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Measuring Sleep Disturbance Among Cancer Patients

Completed
  • Advanced Cancer
  • Questionnaire
  • Actigraph
  • Houston, Texas
  • +1 more
Jul 12, 2022

Advanced Cancer Trial in United States (AGEN1777, a PD-1 inhibitor)

Recruiting
  • Advanced Cancer
  • Grand Rapids, Michigan
  • +5 more
Jun 8, 2022

Advanced Cancer, Anorexia, Weight Loss Trial in Houston (Mirtazapine, Placebo)

Suspended
  • Advanced Cancer
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 26, 2022

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)

Active, not recruiting
  • Advanced Cancer
  • +4 more
  • Saint Louis, Missouri
  • +3 more
Apr 4, 2022